Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors

被引：0
|
作者：
R. Rodia
F. Pani
G. Caocci
G. La Nasa
M. P. Simula
O. Mulas
F. Velluzzi
A. Loviselli
S. Mariotti
F. Boi
机构：
[1] Azienda Ospedaliero-Universitaria di Cagliari,Endocrinology Unit, Department of Medical Sciences and Public Health, University of Cagliari
[2] The Johns Hopkins School of Medicine,Division of Immunology, Department of Pathology
[3] Businco Hospital,Ematology and CTMO
[4] Azienda Ospedaliera Brotzu,undefined
来源：
Journal of Endocrinological Investigation | 2022年 / 45卷
关键词：
Tyrosine kinase inhibitors; Thyroid abnormalities; Chronic myeloid leukemia; Thyroid autoimmunity; Molecular response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 300
页数：9
相关论文
共 50 条
  • [1] Thyroid autoimmunity and hypothyroidism are associated with deep molecular response in patients with chronic myeloid leukemia on tyrosine kinase inhibitors
    Rodia, R.
    Pani, F.
    Caocci, G.
    La Nasa, G.
    Simula, M. P.
    Mulas, O.
    Velluzzi, F.
    Loviselli, A.
    Mariotti, S.
    Boi, F.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (02) : 291 - 300
  • [2] Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia
    Frikha, Rim
    Kassar, Olfa
    Elloumi, Moez
    Kamoun, Hassen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1826 - 1831
  • [3] IMPACT OF DOSE REDUCTION OF TYROSINE KINASE INHIBITORS IN THE MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Saez Perdomo, M. N.
    Gonzalez Perez, E.
    Luzardo, H.
    Gonzalez Brito, G.
    Gonzalez San Miguel, J. D.
    Afonso, V
    Gordillo, M.
    Herranz, N.
    Tapia, M.
    Bilbao, C.
    Gomez Casares, M. T.
    HAEMATOLOGICA, 2017, 102 : 279 - 280
  • [4] Molecular studies in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Sawyers, CL
    SEMINARS IN HEMATOLOGY, 2001, 38 (03) : 15 - 21
  • [5] Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemia
    Mauro, Michael J.
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (02) : 119 - 123
  • [6] Genotoxicity associated with the use of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
    Maia Filho, Pedro Aurio
    de Almeida Filho, Tarcisio Paulo
    Aquino Moreina-Nunes, Caroline de Fatima
    Burbano, Rommel Rodriguez
    Rodrigues de Lemos, Jose Alexandre
    Correa de Oliveira, Edivaldo Herculano
    Cavalcanti, Bruno Coelho
    Pereira, Jamilly Florencio
    Barbosa, Maritza Cavalcante
    Duarte, Fernando Barroso
    de Castro, Marilena Facundo
    de Souza Quixada, Acy Telles
    Goncalves Lemes, Romelia Pinheiro
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2018, 59 (03) : 260 - 262
  • [7] EXPERIENCE IN REAL CLINICAL PRACTICE OF SUSPENSION OF TREATMENT WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN DEEP MOLECULAR RESPONSE
    Martinez-Barranco, P.
    Barcia, I
    Villalon, L.
    Garcia Roa, M.
    Ricard, P.
    Arribalzaga, K.
    Garcia Bueno, M. J.
    Perez-Fernandez, E.
    Penalver Parraga, F. J.
    HAEMATOLOGICA, 2019, 104 : 301 - 302
  • [8] Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors
    Cayssials, Emilie
    Tartarin, Florence
    Guilhot, Joelle
    Sorel, Nathalie
    Chomel, Jean Claude
    Leleu, Xavier
    Guilhot, Francois
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 766 - 769
  • [9] Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Yeung, David T.
    Mauro, Michael J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 240 - 243
  • [10] Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia
    Abdallah, Aya M.
    Hafez, Hanafy
    Madney, Youssef
    Ahmed, Sonia
    Yassin, Dina
    Salem, Sherine
    Yousry, Rodina
    Abdel-Azim, Hisham
    Lehmann, Leslie
    Elhaddad, Alaa
    LEUKEMIA & LYMPHOMA, 2024, 65 (07) : 1024 - 1027
12345